Xavier University is hosting the FDA/Xavier PharmaLink Conference March 11-14. The event brings together industry experts and the FDA to discuss and solve challenges in the field. The focus of the meeting revolves around the FDA Safety and Innovation Act (FDASIA) which is influencing new regulations. Invited speaker John Taylor, Counselor to the Commissioner will address the FDA’s strategy for FDASIA implementation and the impact of the legislation on global supply chain. John Lechleiter, CEO, President and Chairman of Eli Lilly with provide the Xavier PharmaLink Dinner Keynote speech. For additional plenary topics and the agenda, click here. Early Registration is now open, click here.
Where: Xavier University – Cintas Center, 1624 Herald Avenue, Cincinnati, Ohio 45207
When: March 11-14, 2013
Cost*: $200-$995 on or before 1/22/13
$300-$1,495 after 2/18/2013
*depends on registrant affiliation, click here for more details